Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |